Fingerprint
Dive into the research topics of 'Efficacy and safety of once-Weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): A 56-Week, open-Label, randomized clinical trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically